Catheter Precision, Inc.
VTAK
$1.08
$0.032.86%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 81.51% | 5.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 81.51% | 5.31% | |||
| Cost of Revenue | 110.00% | 11.11% | |||
| Gross Profit | 78.90% | 4.81% | |||
| SG&A Expenses | -7.15% | -6.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.40% | -4.40% | |||
| Operating Income | 19.12% | 5.13% | |||
| Income Before Tax | 69.23% | -167.52% | |||
| Income Tax Expenses | 18.22% | -374.36% | |||
| Earnings from Continuing Operations | 71.10% | -149.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -87.14% | -24.73% | |||
| Net Income | 70.91% | -156.69% | |||
| EBIT | 19.12% | 5.13% | |||
| EBITDA | 18.21% | 6.18% | |||
| EPS Basic | 59.29% | -99.91% | |||
| Normalized Basic EPS | -133.26% | 258.36% | |||
| EPS Diluted | 59.29% | -99.91% | |||
| Normalized Diluted EPS | -133.26% | 258.36% | |||
| Average Basic Shares Outstanding | 29.26% | 28.40% | |||
| Average Diluted Shares Outstanding | 29.26% | 28.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||